bilobalide has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, GZ; Niu, TT; Yuan, BY | 1 |
| Cao, Z; Cui, C; Hou, Y; Klein, WL; Lacor, PN; Lao, L; Luo, Y; Tchantchou, F | 1 |
| Ahlemeyer, B; Krieglstein, J | 1 |
2 review(s) available for bilobalide and Alzheimer Disease
| Article | Year |
|---|---|
Ginkgolides and bilobalide for treatment of Alzheimer's disease and COVID-19: potential mechanisms of action.
Topics: Alzheimer Disease; Bilobalides; COVID-19; Ginkgo biloba; Ginkgolides; Humans; Plant Extracts; Plaque, Amyloid; SARS-CoV-2 | 2022 |
Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Apoptosis; Brain Ischemia; Cells, Cultured; Cyclopentanes; Diterpenes; Dose-Response Relationship, Drug; Drug Interactions; Flavones; Flavonoids; Furans; Ginkgo biloba; Ginkgolides; Glutamic Acid; Humans; Hypoxia; Lactones; Neurons; Neuroprotective Agents; Plant Extracts; Time Factors | 2003 |
1 other study(ies) available for bilobalide and Alzheimer Disease
| Article | Year |
|---|---|
Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons.
Topics: Alzheimer Disease; Animals; Blotting, Western; Cyclic AMP Response Element-Binding Protein; Cyclopentanes; Dose-Response Relationship, Drug; Furans; Ginkgo biloba; Ginkgolides; Hippocampus; Mice; Neurogenesis; Phosphorylation; Plant Extracts; Quercetin; Rats; Rats, Sprague-Dawley; Synapses | 2009 |